🔎 Trials Near Me

Home › B-Cell Lymphoma

B-Cell Lymphoma clinical trials recruiting in the U.S.

67 studies for B-Cell Lymphoma are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06350318

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07439653

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07101328

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05615636

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

RecruitingPhase 1/2
31 Days – 30 Years · All sexes · Updated Sep 14, 2026 · NCT04544592

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06526793

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT05272384

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06564038

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06393738

Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma

RecruitingObservational study
Ages 4 and older · All sexes · Updated Sep 3, 2026 · NCT07652580

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT07516093

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT07520006

A Study of ARC-02 in B-cell NHL

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT07691606

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Aug 25, 2026 · NCT05389423

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535

A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07220616

Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT04792502

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT04104776

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.